Article
The comprehensive expression of BCL2 family genes determines the prognosis of diffuse large B-cell lymphoma]{The comprehensive expression of BCL2 family genes determines the prognosis of diffuse large B-cell lymphoma
2023-05-02
Abstract excerpt
Diffuse large B-cell lymphoma (DLBCL) is a prevalent and aggressive non-Hodgkin’s lymphoma, and 40% of patients succumb to death. Despite numerousclinical trials aimed at developing treatment strategies beyond the conven-tional R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, andprednisone) regimen, there have been no positive results thus far. Although theselective BCL2 inhibitor venetoclax has show...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6a12864f-ec03-567a-a02e-fd56bf030075
- DOI
- 10.21203/rs.3.rs-2857911/v1
